Brief: Biosynex Q3 Revenue Up At 84.8 Million Euros
Oct 14 (Reuters) - BIOSYNEX SA ALBIO.PA :
* Q3 REVENUE EUR 84.8 MILLION, MULTIPLIED BY 3 COMPARED TO
Q3 2020
* BIOSYNEX WILL CONTINUE ITS EFFORTS TO PENETRATE NEW
INTERNATIONAL MARKETS FOR ITS SARS-COV-2 TESTS
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals